Doctor profile · Federal record
Dr. Mabel Mardones, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Hematology & Oncology Physician · Student in an Organized Health Care Education/Training Program · Denver, CO
- NPI 1134446461
- Accepts Medicare
- MIPS 81.5 / 100 · 2023
- 16 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4700 Hale Pkwy Ste 400
Denver, CO 802204051
(033) 210-3023
fax (303) 321-9296 - Mailing address
-
7951 E Maplewood Ave Ste 350
Greenwood Village, CO 801114758
Credentials & registration
- NPI registered
- April 2010 — 16 yrs on file
- Profile last updated
- February 17, 2025
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Colorado #DR.0060709 · Texas #P8274
- Medicaid (3)
- TX #333672901 · TX #333672902 · CO #9000165257
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134446461. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
31,807
Distinct HCPCS
10
Medicare allowed
$1,084,367
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 10,500 | 21 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 8,100 | 21 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 3,780 | 28 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,475 | 41 | $0 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 910 | 22 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 766 | 282 | $8 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 750 | 27 | $1 | |
80053 |
Blood test, comprehensive group of blood chemicals | 699 | 264 | $10 | |
82378 |
Carcinoembryonic antigen (cea) protein level | 656 | 289 | $19 | |
86300 |
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 650 | 288 | $20 |
In context: peer comparison
Among 15 peers in this city , average services per provider: 845. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$10,172
Transactions
17
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $4,932.98 | |
| Stemline Therapeutics Inc. | 2 | $2,653.06 | |
| AstraZeneca Pharmaceuticals LP | 5 | $2,363.16 | |
| Janssen Biotech, Inc. | 1 | $99.95 | |
| PUMA BIOTECHNOLOGY, INC. | 1 | $53.16 | |
| Merck Sharp & Dohme LLC | 1 | $26.65 | |
| Gilead Sciences, Inc. | 1 | $24.94 | |
| Lilly USA, LLC | 1 | $17.89 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
803
Patients
210
Total drug cost
$437,715
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 373 | 114 | $8,866 |
| Tamoxifen Citrate | Generic | 136 | 46 | $3,534 |
| Exemestane | Generic | 64 | 17 | $15,308 |
| Gabapentin | Generic | 58 | 14 | $1,047 |
| Letrozole | Generic | 47 | 19 | $1,668 |
| Ibrance (Palbociclib) | Brand | 24 | 0 | $382,189 |
| Megestrol Acetate | Generic | 18 | 0 | $185 |
| Xarelto (Rivaroxaban) | Brand | 18 | 0 | $24,099 |
| Potassium Chloride | Generic | 15 | 0 | $333 |
| Prednisone | Generic | 14 | 0 | $49 |
Hospital affiliations
Frequently asked questions
What is Dr. Mabel Mardones's medical specialty?
Dr. Mabel Mardones practices Hematology & Oncology Physician in Denver, CO.
Where does Dr. Mabel Mardones practice?
Dr. Mabel Mardones practices at 4700 Hale Pkwy Ste 400, Denver, CO 802204051. Office phone: 0332103023.
What is Dr. Mabel Mardones's NPI?
Dr. Mabel Mardones's National Provider Identifier (NPI) is 1134446461, issued by NPPES.
Does Dr. Mabel Mardones accept Medicare assignment?
Yes. Dr. Mabel Mardones accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mabel Mardones commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.